Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
Karoon Kiani F, Izadi S, Ansari Dezfouli E, Ebrahimi F, Mohammadi M, Chalajour H, Mortazavi Bulus M, Nasr Esfahani M, Karpisheh V, Mahmoud Salehi Khesht A, Abbaszadeh-Goudarzi K, Soleimani A, Gholizadeh Navashenaq J, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Shahmohammadi Farid S, Hashemi V, Jadidi-Niaragh F. Karoon Kiani F, et al. Among authors: chalajour h. Life Sci. 2022 Jan 1;288:120166. doi: 10.1016/j.lfs.2021.120166. Epub 2021 Nov 20. Life Sci. 2022. Retraction in: Life Sci. 2024 Aug 1;350:122775. doi: 10.1016/j.lfs.2024.122775 PMID: 34813798 Retracted.
PD-L1/PD-1 axis as a potent therapeutic target in breast cancer.
Bastaki S, Irandoust M, Ahmadi A, Hojjat-Farsangi M, Ambrose P, Hallaj S, Edalati M, Ghalamfarsa G, Azizi G, Yousefi M, Chalajour H, Jadidi-Niaragh F. Bastaki S, et al. Among authors: chalajour h. Life Sci. 2020 Apr 15;247:117437. doi: 10.1016/j.lfs.2020.117437. Epub 2020 Feb 16. Life Sci. 2020. PMID: 32070710 Review.
Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].
Kiani FK, Izadi S, Dezfouli EA, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MM, Esfahani MN, Karpisheh V, Khesht AMS, Abbaszadeh-Goudarzi K, Soleimani A, Navashenaq JG, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Farid SS, Hashemi V, Jadidi-Niaragh F. Kiani FK, et al. Among authors: chalajour h. Life Sci. 2024 Aug 1;350:122775. doi: 10.1016/j.lfs.2024.122775. Epub 2024 Jun 8. Life Sci. 2024. PMID: 38851943 No abstract available.